Citation: L. Kittler et al., SEQUENCE-SPECIFIC MODULATION OF DNA RESTRICTION ENZYME CLEAVAGE BY MINOR-GROOVE BINDERS, Biological chemistry, 379(4-5), 1998, pp. 519-525
Authors:
PANG JH
CAO Z
JOSEPH WR
BAGULEY BC
CHING LM
Citation: Jh. Pang et al., ANTITUMOR-ACTIVITY OF THE NOVEL IMMUNE MODULATOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA) IN MICE LACKING THE INTERFERON-GAMMA RECEPTOR, European journal of cancer, 34(8), 1998, pp. 1282-1289
Authors:
BAGULEY BC
MARSHALL ES
HOLDAWAY IM
REWCASTLE GW
DENNY WA
Citation: Bc. Baguley et al., INHIBITION OF GROWTH OF PRIMARY HUMAN TUMOR-CELL CULTURES BY A 4-ANILINOQUINAZOLINE INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR FAMILY OF TYROSINE KINASES, European journal of cancer, 34(7), 1998, pp. 1086-1090
Authors:
BAGULEY BC
BRIDEWELL DJA
FINLAY GJ
MARSHALL ES
DANGERFIELD W
TEMPLETON D
Citation: Bc. Baguley et al., THE ROLES OF TOPOISOMERASE-I AND TOPOISOMERASE-II IN THE CYTOTOXICITYOF DACA (N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE DIHYDROCHLORIDE), Annals of oncology, 9, 1998, pp. 239-239
Authors:
SCRENCI D
GALETTIS P
BAGULEY BC
MCKEAGE MJ
Citation: D. Screnci et al., OPTIMIZATION OF AN ICP-MS ASSAY FOR THE DETECTION OF TRACE LEVELS OF PLATINUM IN PERIPHERAL-NERVES, Atomic spectroscopy, 19(5), 1998, pp. 172-175
Citation: Bc. Baguley et Lr. Ferguson, MUTAGENIC PROPERTIES OF TOPOISOMERASE-TARGETED DRUGS, Biochimica et biophysica acta, N. Gene structure and expression, 1400(1-3), 1998, pp. 213-222
Citation: Iew. Obrien et al., MAJOR CHANGES IN CHROMATIN CONDENSATION SUGGEST THE PRESENCE OF AN APOPTOTIC PATHWAY IN PLANT-CELLS, Experimental cell research, 241(1), 1998, pp. 46-54
Authors:
LASH CJ
LI AE
RUTLAND M
BAGULEY BC
ZWI LJ
WILSON WR
Citation: Cj. Lash et al., ENHANCEMENT OF THE ANTITUMOR EFFECTS OF THE ANTIVASCULAR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA) BY COMBINATION WITH 5-HYDROXYTRYPTAMINE AND BIOREDUCTIVE DRUGS, British Journal of Cancer, 78(4), 1998, pp. 439-445
Authors:
CHING LM
BROWNE WL
TCHERNEGOVSKI R
GREGORY T
BAGULEY BC
PALMER BD
Citation: Lm. Ching et al., INTERACTION OF THALIDOMIDE, PHTHALIMIDE ANALOGS OF THALIDOMIDE AND PENTOXIFYLLINE WITH THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID - CONCOMITANT REDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND ENHANCEMENT OF ANTITUMOR-ACTIVITY, British Journal of Cancer, 78(3), 1998, pp. 336-343
Citation: Bc. Baguley et Es. Marshall, PRIMARY CULTURES OF HUMAN TUMORS - IN-VIVO INSIGHTS FROM IN-VITRO RESULTS, British Journal of Cancer, 78, 1998, pp. 1-1
Authors:
KITTLER L
MATESOI D
BELL A
BAGULEY BC
UNGER E
LOBER G
Citation: L. Kittler et al., SEQUENCE-SPECIFIC INTERACTIONS OF MINOR-GROOVE BINDERS WITH THE 154 BASE-PAIR HINDIII-RSAI RESTRICTION FRAGMENT OF CDNA OF THE HUMAN TAU-40PROTEIN INVOLVED IN PATHOLOGY OF ALZHEIMERS-DISEASE, Biochemistry and molecular biology international, 41(1), 1997, pp. 143-152
Authors:
BRADY F
LUTHRA SK
BROWN G
OSMAN S
HARTE RJA
DENNY WA
BAGULEY BC
JONES T
PRICE PM
Citation: F. Brady et al., C-11 LABELING OF THE ANTITUMOR AGENT N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE (DACA) AND DETERMINATION OF PLASMA METABOLITES IN MAN, Applied radiation and isotopes, 48(4), 1997, pp. 487-492
Citation: Bc. Baguley et al., INCREASED PLASMA SEROTONIN FOLLOWING TREATMENT WITH FLAVONE-8-ACETIC ACID, 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, VINBLASTINE, AND COLCHICINE - RELATION TO VASCULAR EFFECTS, Oncology research, 9(2), 1997, pp. 55-60
Citation: Dja. Bridewell et al., DIFFERENTIAL ACTIONS OF ACLARUBICIN AND DOXORUBICIN - THE ROLE OF TOPOISOMERASE-I, Oncology research, 9(10), 1997, pp. 535-542
Authors:
BAGULEY BC
LETEURTRE F
RIOU JF
FINLAY GJ
POMMIER Y
Citation: Bc. Baguley et al., A CARBAMATE ANALOG OF AMSACRINE WITH ACTIVITY AGAINST NON-CYCLING CELLS STIMULATES TOPOISOMERASE-II CLEAVAGE AT DNA SITES DISTINCT FROM THOSE OF AMSACRINE, European journal of cancer, 33(2), 1997, pp. 272-279
Authors:
MORELAND N
FINLAY GJ
DRAGUNOW M
HOLDAWAY KM
BAGULEY BC
Citation: N. Moreland et al., CELLULAR-RESPONSES TO -N-[4-(9-ACRIDINYLAMINO)-2-METHOXYPHENYL]CARBAMATE HYDROCHLORIDE, AN ANALOG OF AMSACRINE ACTIVE AGAINST NONPROLIFERATING CELLS, European journal of cancer, 33(10), 1997, pp. 1668-1676
Authors:
DAVEY RA
SU GM
HARGRAVE RM
HARVIE RM
BAGULEY BC
DAVEY MW
Citation: Ra. Davey et al., THE POTENTIAL OF N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE TO CIRCUMVENT 3 MULTIDRUG-RESISTANCE PHENOTYPES IN-VITRO, Cancer chemotherapy and pharmacology, 39(5), 1997, pp. 424-430
Authors:
FAN JY
VALU KK
WOODGATE PD
BAGULEY BC
DENNY WA
Citation: Jy. Fan et al., ANILINE MUSTARD ANALOGS OF THE DNA-INTERCALATING AGENT AMSACRINE - DNA INTERACTION AND BIOLOGICAL-ACTIVITY, Anti-cancer drug design, 12(3), 1997, pp. 181-203
Authors:
DEADY LW
KAYE AJ
FINLAY GJ
BAGULEY BC
DENNY WA
Citation: Lw. Deady et al., SYNTHESIS AND ANTITUMOR PROPERTIES OF N-[2-(DIMETHYLAMINO)ETHYL]CARBOXAMIDE DERIVATIVES OF FUSED TETRACYCLIC QUINOLINES AND QUINOXALINES - A NEW CLASS OF PUTATIVE TOPOISOMERASE INHIBITORS, Journal of medicinal chemistry, 40(13), 1997, pp. 2040-2046
Authors:
SPICER JA
GAMAGE SA
ATWELL GJ
FINLAY GJ
BAGULEY BC
DENNY WA
Citation: Ja. Spicer et al., STRUCTURE-ACTIVITY-RELATIONSHIPS FOR ACRIDINE-SUBSTITUTED ANALOGS OF THE MIXED TOPOISOMERASE I II INHIBITOR N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE/, Journal of medicinal chemistry, 40(12), 1997, pp. 1919-1929
Authors:
TE C
GENTILE JM
BAGULEY BC
PEARSON AE
GREGORY T
FERGUSON LR
Citation: C. Te et al., IN-VIVO EFFECTS OF CHLOROPHYLLIN ON THE ANTITUMOR AGENT CYCLOPHOSPHAMIDE, International journal of cancer, 70(1), 1997, pp. 84-89
Authors:
MINERS JO
VALENTE L
LILLYWHITE KJ
MACKENZIE PI
BURCHELL B
BAGULEY BC
KESTELL P
Citation: Jo. Miners et al., PRECLINICAL PREDICTION OF FACTORS INFLUENCING THE ELIMINATION OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, A NEW ANTICANCER DRUG, Cancer research, 57(2), 1997, pp. 284-289
Authors:
OSMAN S
LUTHRA SK
BRADY F
HUME SP
BROWN G
HARTE RJA
MATTHEWS JC
DENNY WA
BAGULEY BC
JONES T
PRICE PM
Citation: S. Osman et al., STUDIES ON THE METABOLISM OF THE NOVEL ANTITUMOR AGENT 1]N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE IN RATS AND HUMANS PRIOR TO PHASE-I CLINICAL-TRIALS, Cancer research, 57(11), 1997, pp. 2172-2180